Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Heat-shock protein expression modulation in RPE cells" refers not to a single molecular target but rather a **cellular process** involving several members of the heat-shock protein family—most notably **HSP27**, **HSP70**, and **HSP90**—within retinal pigment epithelial cells. These chaperone proteins are upregulated under conditions such as oxidative stress or injury. For example, increased expression of **HSP27** correlates with improved viability and altered membrane blebbing after injury; it is hypothesized that this plays a protective role during age-related macular degeneration and other retinal diseases by maintaining cytoskeletal integrity and regulating apoptosis[2][3]. Similarly, **HSP90** helps protect against oxidative damage but can also regulate inflammatory cytokine secretion via pathways like NF-kB; its inhibition suppresses pro-senescent signaling phenotypes in vitro using drugs such as IPI‐504[1]. Small heat-shock proteins also interact with misfolded or partially unfolded client proteins to prevent aggregation—a function critical for neuroprotection—and participate broadly in angiogenesis regulation relevant for neovascular eye diseases[4]. Modulation of these pathways is being explored therapeutically but presents challenges due to their essential roles across many tissues. Note on correctness: The provided target name ("Heat-shock protein expression modulation in RPE cells") describes a biological process rather than an individual molecule/receptor. For structured data purposes, it should be mapped instead to specific targets such as "Heat shock protein 27," "Heat shock 70 kDa protein," or "Heat shock 90 kDa protein" depending on context.
Inhibition of ATPase activity of heat shock proteins to modulate cellular stress responses and senescence-associated secretory phenotype
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock protein (HSP) expression in retinal pigment epithelial cell (HSP (in the context of RPE cells, specific isoforms include Hsp27, Hsp70, Hsp90)).